1 – 6 of 6
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
The MHC class II transactivator modulates seeded alpha-synuclein pathology and dopaminergic neurodegeneration in an in vivo rat model of Parkinson's disease
(
- Contribution to journal › Article
- 2019
-
Mark
Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer’s disease
(
- Contribution to journal › Article
- 2018
-
Mark
Microglia in neurological diseases : A road map to brain-disease dependent-inflammatory response
(
- Contribution to journal › Scientific review
- 2017
-
Mark
Allelic difference in Mhc2ta confers altered microglial activation and susceptibility to α-synuclein-induced dopaminergic neurodegeneration
(
- Contribution to journal › Article
- 2009
-
Mark
Differential nerve injury-induced expression of MHC class II in the mouse correlates to genetic variability in the type I promoter of C2ta
(
- Contribution to journal › Article
- 2003
-
Mark
Discrete gene loci regulate neurodegeneration, lymphocyte infiltration, and major histocompatibility complex class II expression in the CNS
2003) In The Journal of Neuroscience : the official journal of the Society for Neuroscience 23(30). p.23-9817(
- Contribution to journal › Article